Publications by authors named "William Tap"

Claim this Profile
A
Association of early dexrazoxane with reduced cardiotoxicity risk in sarcoma patients treated with anthracycline chemotherapy.
Kristine H Jang, Joseph S Wallins, I-Hsin Lin, Sujana Movva, William D Tap

Oncologist· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tumor and Immune Dynamics Following Sequential CDK4/6 and PD-1 Inhibition: Results from a Phase 2 Study in Dedifferentiated Liposarcoma.
Evan Rosenbaum, Rodrigo Gularte-Mérida, Evan Seffar, Jasme Lee, Mathew Adamow, William D Tap

Cancer Res Commun· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
How to foster new treatment development in ultra-rare tumours? Joint EMA-EORTC multi-stakeholder workshops on ultra-rare sarcomas as a model for rare cancers.
Silvia Stacchiotti, Pan Pantziarka, Hugh Leonard, Caroline Voltz, Laura Abatedaga, William D Tap

Cancer Treat Rev· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Deep-Learning Tool ScVital Enables Species-Agnostic Integration of Cancer Cell States.
Jonathan Rub, Jason E Chan, Carleigh Sussman, Gary Guzman, William D Tap

Cancer Res· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Paired tumor-normal sequencing provides insights into the CDKN2A-associated tumor spectrum.
Kelsey E Breen, Nikita Mehta, Vignesh Ravichandran, Miika Mehine, Chuan Gao, William D Tap

NPJ Precis Oncol· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
ctDNA as a Molecular Biomarker in the Phase II Trial of Imatinib plus Binimetinib in Patients with Advanced Gastrointestinal Stromal Tumor.
Ciara M Kelly, Martina Bradic, Sara Saunds, Viswatej Avutu, Lauren Banks, William D Tap

Clin Cancer Res· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Guidelines for Next-Generation Sequencing in Sarcoma Diagnosis and Treatment: A Consensus Review.
César Serrano, Sebastian Bauer, Jean-Yves Blay, Paolo G Casali, Carlo M Cicala, William Tap

JAMA Oncol· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Spectrum and Clinical Impact of Secondary Genetic Alterations in Translocation-Associated Sarcomas.
Hsin-Yi Chang, William Tap, Emily Slotkin, Leonard Wexler, Damon Reed

JCO Precis Oncol· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
High transposable element expression in sarcomas is associated with increased immune infiltrates and improved outcomes including after immunotherapy.
Benjamin A Nacev, Martina Bradic, Hyung Jun Woo, Allison L Richards, Ciara M Kelly, William D Tap

J Immunother Cancer· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Undifferentiated Pleomorphic Sarcoma in Children and Young Adults: A Comprehensive Clinicopathologic, Genomic, and Epigenetic Comparison With Adult Counterparts.
Carla Saoud, Gunes Gundem, Chad M Vanderbilt, Leonard H Wexler, Damon R Reed, William Tap

Mod Pathol· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The economic and humanistic burden of tenosynovial giant cell tumor: a targeted literature review.
Michiel van de Sande, Jean-Yves Blay, William Tap, Max Lee, Emily Kaiser

Future Oncol· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-world experience of patients newly initiated on pexidartinib for tenosynovial giant cell tumor.
Dong Dai, Kristen Tecson, Irene Pan, Xin Ye, William Tap

Future Oncol· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of Acupuncture and Massage on Pain in Adolescent and Young Adult Patients with Advanced Cancer: Subgroup Analysis of a Randomized Clinical Trial.
Han-Wei V Wu, Xiaotong Li, Qing S Li, Raymond E Baser, Katherine S Panageas, William D Tap

J Adolesc Young Adult Oncol· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Secondary Genetic Alterations in Extraskeletal Myxoid Chondrosarcoma.
Yamato Suemitsu, Hsin-Yi Chang, Carla Saoud, Josephine K Dermawan, Meera Hameed, William D Tap

Genes Chromosomes Cancer· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Methylation Analysis Reveals Epigenetic Congruence Between Bone Sarcomas With H3-3A Mutations and Malignant Giant Cell Tumors of Bone.
Carla Saoud, Jamal Benhamida, Laetitia Borsu, Liliana Villafania, Konstantinos Linos, William Tap

Mod Pathol· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term efficacy and safety of pexidartinib in patients with tenosynovial giant cell tumor: final results of the ENLIVEN study.
Andrew J Wagner, William D Tap, Sebastian Bauer, Jean-Yves Blay, Jayesh Desai

Oncologist· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase I Study of the Mutant IDH1 Inhibitor Ivosidenib: Long-term Safety and Clinical Activity in Patients with Conventional Chondrosarcoma.
William D Tap, Gregory M Cote, Howard Burris, Lia Gore, Anthony Elias

Clin Cancer Res· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase II study of rucaparib and nivolumab in patients with leiomyosarcoma.
Sujana Movva, Kenneth Seier, Martina Bradic, Karmelina Charalambous, Evan Rosenbaum, William Tap

J Immunother Cancer· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Localized and diffuse tenosynovial giant cell tumor: real-world results from a patient observational registry.
Sydney Stern, Patrick F McKenzie, Nicholas Bernthal, Shannon O'Neill, Emanuela Palmerini, William Tap

Future Oncol· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Germline pathogenic variants in DNA repair pathways: a key feature in a significant subset of translocation-associated sarcomas.
Carla Saoud, Josephine K Dermawan, Kanika Arora, William D Tap, Damon Reed

NPJ Precis Oncol· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
ACR-368, a CHK1/2 Kinase Inhibitor, in Patients With Relapsed or Refractory Desmoplastic Small Round Cell Tumor: Phase I/II Trial Results.
Emily K Slotkin, Audrey Mauguen, Filemon S Dela Cruz, Michael V Ortiz, Viswatej Avutu, William D Tap

JCO Oncol Adv· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Alternative driver pathways in peripheral nerve sheath tumors - including DICER1 and/or KRAS alterations.
Hsin-Yi Chang, Carla Saoud, Dianne Torrence, William Tap, Ping Chi

J Pathol· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunologic correlates in a CIC::DUX4 fusion-positive sarcoma responsive to dual immune checkpoint blockade.
Olayode O Babatunde, Sara Coca Membribes, Cristina Anthonescu, Martina Bradic, Bernard O'Malley, William D Tap

NPJ Precis Oncol· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Patient-reported continued benefits of pexidartinib for tenosynovial giant cell tumor based on a real-world study in the United States.
Dong Dai, Irene Pan, Klaus Freivogel, Xin Ye, Kristen Tecson, William Tap

Oncologist· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeting HER2 in lung cancers: Evolving treatment landscape and drug development strategies.
Daniel Reinhorn, Mor Moskovitz, William D Tap, Bob T Li

Cancer· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis